I find it interesting to draw parallels between theories we see in the Life Expectancy space and what was considered state-of-the-art medical treatment throughout history. Procedures once considered vital have been studied and debunked as unsafe. For example: bloodletting, a medical procedure widely accepted by ancient Egyptians, Greeks, Romans, was still used in the 18th century. Bloodletting was performed on George Washington in December 1799, likely… 

Want to read the full article?

You can read this article and more on LifeRisk.news.

Read Article

Insurers are favouring funded re as it helps firms manage the market and longevity risks associated with writing bulk purchase annuity (BPA) business by reducing capital charges and therefore making PRT deals more competitive. 

Unsurprisingly, given its growth and potential for capital optimisation, UK regulators have been carefully watching the increased use of funded re. In June 2023, the Prudential Regulatory Authority (PRA) sent a “Dear CRO’ letter to heads of risk at UK life insurers.

The letter outlined the regulator’s two main concerns from a sectoral review which it had carried out.

“One of the key risks arising in funded re is that firms recapture sub-optimal portfolios with depressed values and with limited ability to be transformed effectively to the firms’ preferred portfolio,” the PRA letter said.

Post a comment

Your email address will not be published.

Related Posts